Biotech Values

[jbog]

Britain and Germany to offer COVID-19 booster shots; U.S. waits for more data
Amid rising concerns over the highly transmissible Delta variant of the coronavirus, Britain and Germany have announced plans to vaccinate their populations with COVID-19 booster shots.

Britain is set to offer boosters to 32M of its citizens starting as early as next month, The Telegraph reported.

With the partnership of up to 2,000 pharmacies to deliver the program, the campaign is likely to kick off on September 06 targeting those aged 50 years and older as well as the immuno-suppressed.

Meanwhile, from September, Germany will also start offering booster shots for those who are eligible, the country’s health minister said Monday.

Booster doses in the form of Pfizer (NYSE:PFE)/ BioNTech (NASDAQ:BNTX) and Moderna (NASDAQ:MRNA) vaccines will be offered to anyone regardless of the vaccine they received initially.
The minister said the vaccines will be made more accessible to those aged 12 – 17 years, going a step further than the country’s vaccines regulator which has only recommended COVID-19 vaccines for adolescents with pre-existing conditions or those who are at high risk of having the disease.

Speaking to Bloomberg, Peter Marks, the head of the FDA unit responsible for reviewing vaccines for approval, said on Monday that the U.S. will consider the data submitted by the companies as well as those from other countries in considering vaccine boosters.
“There, we will look at the data that the companies have, but we'll also look at the data coming out of countries like Israel, data coming out of studies in the United States, and real-world evidence that we get our hands on from other countries,” Marks said referring to boosters for the general population.